Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. - Wikidata - awgldk - TriplyDB

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer.

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer.

http://www.wikidata.org/entity/Q44641247

about

Prevention of infection-related cancers in the WHO Western Pacific Region Age-specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta-analysis.A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women Differences in age-specific HPV prevalence between self-collected and health personnel collected specimen in a cross-sectional study in Ghana.Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women.Human papillomavirus types 52 and 58 are prevalent in uterine cervical squamous lesions from Japanese women.The cultural context of teaching and learning sexual health care examinations in Japan: a mixed methods case study assessing the use of standardized patient instructors among Japanese family physician trainees of the Shizuoka Family Medicine Program Genomic polymorphism of human papillomavirus type 52 in women from Northeast China Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity Genotype distribution of human papillomaviruses in Japanese women with abnormal cervical cytology.p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping The Japanese guideline for cervical cancer screening.Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.Human papillomavirus infection and the risk of cervical cancer in Japan.Prospective evaluation of the Amplicor HPV test for predicting progression of cervical intraepithelial neoplasia 2.Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2/3 and invasive cervical cancer in Japanese women.Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.Incidence of human papillomavirus contamination of transvaginal probes in Japan and possible contamination prevention strategy.Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer.Viral load and integration status of HPV58 associated with cervical lesion severity in women of Northeast China.Population-based study for human papillomavirus (HPV) infection in young women in Japan: A multicenter study by the Japanese human papillomavirus disease education research survey group (J-HERS).HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.How adolescent Japanese girls arrive at human papilloma virus vaccination: A semistructured interview study.Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay.Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years.Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women.High-risk human papillomavirus associated with incident cervical intraepithelial neoplasia developing in mothers in the Finnish Family HPV Study cohort.Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study.Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.Analysis of human papilloma virus type 52 integration status in exfoliated cervical cells.Association of Cervical Cancer Screening with Knowledge of Risk Factors, Access to Health Related Information, Health Profiles, and Health Competence Beliefs among Community-Dwelling Women in Japan Three-year questionnaire survey on human papillomavirus vaccination targeting new female college students.Introducing HPV vaccine and scaling up screening procedures to prevent deaths from cervical cancer in Japan: a cost-effectiveness analysis.Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers.Human papillomavirus genotype and prognosis of cervical cancer: favorable survival of patients with HPV16-positive tumors

P2860

Q26777318-6C21645E-8C95-4B87-8C10-87372EBC3796 Q30252012-B21B5475-B1D0-4FA6-9F62-87DE5A126F85 Q33679663-0D40ED5C-7DD7-4660-9E36-EF3FFFFA1D07 Q33706242-FE2C2806-A463-45FA-9C5F-298C343D37B7 Q34291189-1C32E848-EF72-4F95-8C19-89474F434277 Q35028816-FA3A711F-9931-48B0-B6ED-95E5C56249C6 Q36135057-CEF73B0C-ACEC-461E-B58A-16FFDCA8185C Q36432579-923D7FE1-C7E8-4A09-A27D-1B26BF60E437 Q36525401-FB013D19-C283-498E-BDB6-BEF4E6CAF9E6 Q36540527-3C83EC05-46CF-49B0-8A47-053D98D5AB79 Q37022506-C4AF35E2-DB8E-4C60-A1C3-ACE1584A06DB Q37740813-54F93D39-7512-49CF-B005-1D2304A0EDE4 Q37983132-06C73857-1EBC-42C5-8C65-5B7589E203F8 Q38038280-84B163B7-D74C-429C-BDC3-06E55F3D4715 Q38118374-B52628A6-B275-4D93-A703-13A15524780B Q39139886-98743470-9E00-40F4-9940-73029C10D265 Q39163261-019E0083-6928-48FA-A086-76234B280E6D Q39713690-FD875884-BA81-4EAA-96B5-CC28C0C6D4E0 Q40091466-199FFC21-C376-4CF0-908D-0188B204AD44 Q40341507-26BB36BF-8A5D-4E22-8746-ADF3A9F690E3 Q41120887-7C57E1C0-420F-4822-9F5B-9CE38B457264 Q42172459-74967495-A791-4830-BACE-609AA5EC3A66 Q42221794-79E3FC07-B08D-4ECB-9122-FDF169523608 Q42375482-52EB2CE5-C340-4169-8CA9-FE91FB7B6AEE Q43427868-1494D2EE-7462-458F-84B2-8074FCFFC8C4 Q43946365-617D30D5-AE8A-48B4-8645-E6D2C0EEE314 Q44794336-7DAA49F1-0E2C-43BC-9212-6AC53AD60349 Q45215935-7A6BCEFC-EAEF-4A53-8620-90A68CEBEA58 Q45838374-0CCF095F-D309-42E5-A6F1-A6AC105688D5 Q47110076-6271D162-61ED-4337-93B6-FC6EA032D7B4 Q47134492-E7178F15-A710-49BC-9A42-1E2F84CBFE34 Q50639756-CC859C92-B919-4E6A-8A18-406F302E1369 Q51434170-D9AC204F-9FF7-4348-A062-F5F3E4DBEF0A Q52585308-3009DBFB-F7E4-418E-9402-298C035BE0CA Q53081710-CD3CCA8D-C9A4-409E-966E-64EA08DA21B0 Q57811139-74E05D26-7D92-493C-BAA1-D305ABBD00AC

P2860

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer.

http://www.wikidata.org/entity/Q44641247

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Human papillomavirus infection ...... ific risk for cervical cancer.

@en

Human papillomavirus infection ...... ific risk for cervical cancer.

@nl

type

label

Human papillomavirus infection ...... ific risk for cervical cancer.

@en

Human papillomavirus infection ...... ific risk for cervical cancer.

@nl

prefLabel

Human papillomavirus infection ...... ific risk for cervical cancer.

@en

Human papillomavirus infection ...... ific risk for cervical cancer.

@nl

P1433

Q44641247-35B71F38-C70A-4773-ABC8-B89B4E55BE57

P1476

Q44641247-8B6E29B2-3B22-4613-92E6-DF4488A876F5

P2093

Q44641247-2B1AF007-0392-4A5F-9D60-755636D1D32C

Q44641247-36EA2765-1954-471F-B347-13C0DFD28869

Q44641247-44F0ADB4-CF73-4CCB-A132-C30C9219E144

Q44641247-54D67AC9-F72D-4315-9D04-C3E40B38ADC4

Q44641247-64C88A98-BA2A-4E8F-B856-45EC97D30716

Q44641247-8B172B32-10F5-4E71-8004-8E007823CF8D

Q44641247-96031866-73B5-4E72-A160-1D1B9A3495C7

Q44641247-BEEBEF7A-24A9-4F97-AB73-6517B56E38B8

Q44641247-E110847E-F015-4A33-820B-4E51D3A689FA

Q44641247-E485A32C-633E-4195-8B0B-E7EA43EDF1C4

P2860

Q44641247-A5421A3F-DB76-4D4B-8B05-085BBFE53519

Q44641247-AC6AD105-C3DD-4C60-A056-1D50FF834AF9

P304

Q44641247-FB9A18C4-7543-4BE4-91CD-659F021DA746

P31

Q44641247-ACD1F5FE-EF2B-47BD-A822-F0264933B99B

P356

Q44641247-D159FA2F-DBC4-4338-AA52-D22E87637766

P433

Q44641247-1AE9A56B-804E-47BB-96E7-096F2E64A921

P478

Q44641247-714C71B1-0C32-4171-BD2A-12911F83E74C

P577

Q44641247-31FD9483-F45F-4F90-9838-D732DD31EDB9

P5875

Q44641247-76D33825-FF5E-4A38-AE6C-222DE3F85D24

P698

Q44641247-594975E8-4B68-452E-BF68-F0D4A25B788A

P356

J.1349-7006.2009.01161.X

P1433

P1476

Human papillomavirus infection ...... ific risk for cervical cancer.

@en

P2093

Akinori Oki

http://www.w3.org/2001/XMLSchema#string

Hiromi Hamada

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Ochi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Yoshikawa

http://www.w3.org/2001/XMLSchema#string

Katsumi Someya

http://www.w3.org/2001/XMLSchema#string

Koji Matsumoto

http://www.w3.org/2001/XMLSchema#string

Mamiko Onuki

http://www.w3.org/2001/XMLSchema#string

Naoki Yamada

http://www.w3.org/2001/XMLSchema#string

Sari Nakao

http://www.w3.org/2001/XMLSchema#string

Satoshi Okada

http://www.w3.org/2001/XMLSchema#string

P2860

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.

Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers.

P304

1312-1316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2009.01161.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24418449

http://www.w3.org/2001/XMLSchema#string

P698

19432906

http://www.w3.org/2001/XMLSchema#string